Related Experiment Video
Updated: Jul 29, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Cefixime for the prophylaxis of urinary tract infections in children with malformative uropathies: an open study
G Stranieri1, S Zampogna, V Ielapi
1Struttura Complessa di Chirurgia Pediatrica, Azienda Ospedaliera Pugliese Ciaccio - Catanzaro, Italy.
Insights
Cefixime, a 3rd generation cephalosporin antibiotic, shows effectiveness in the long-term prophylaxis of urinary tract infections (UTIs) associated with urinary anomalies. This antibiotic is crucial for preventing kidney damage from pyelonephritis, especially with rising bacterial resistance.
Area of Science:
- Urology
- Infectious Diseases
- Pharmacology
Background:
- Urinary tract infections (UTIs) frequently coexist with urinary anomalies.
- Kidney damage from pyelonephritis can be mitigated by appropriate pharmacologic treatment.
- Antibiotic prophylaxis is as vital as early surgical intervention for UTIs, especially with trends toward less aggressive therapies.
Purpose of the Study:
- To evaluate the effectiveness of cefixime in the long-term prophylaxis of UTIs in patients with urinary anomalies.
- To assess cefixime's role in preventing kidney damage in the context of increasing antibiotic resistance.
Main Methods:
- A series of patients with UTIs and associated urinary tract anomalies were treated with cefixime.
- Cefixime, a 3rd generation cephalosporin, was administered for prophylactic treatment.
Main Results:
- Significant positive outcomes were observed in patients receiving cefixime prophylaxis.
- The study highlights the efficacy of cefixime in managing UTIs linked to urinary anomalies.
Conclusions:
- Cefixime demonstrates effectiveness for long-term prophylaxis of UTIs in patients with urinary anomalies.
- The findings support cefixime as a valuable therapeutic option, particularly given current bacterial resistance patterns.
Abstract:
Urinary tract infections are often associated with urinary anomalies. An appropriate pharmacologic treatment may prevent, or may at least limit, any kidney damage due to pyelonephritis. The antibiotic prophylaxis plays a role as significant as early surgical therapy, taking into consideration also the present limitative trend for a softer therapeutic regimen. In the past few years a greater bacterial resistance has emerged against some commonly administered antibiotics. Cefixime (3rd generation cephalosporin) has been used on a wide series of patients suffering from urinary infections associated with urinary tract anomalies. A few significative results emerge from the present study. In conclusion, cefixime's effectiveness long-term prophylaxis of urinary infections associated with anomalies.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urologic Endoscopic Procedure: Cystoscopic Examination
Urine Studies II: Urine Culture and Sensitivity Test

